Terms of Use
Please read the following Terms and Conditions before using the Luitpold Pharmaceuticals, Inc., (Luitpold Pharmaceuticals) Web site. By accessing and using the site, you acknowledge that you have read, understood, and agree to comply with these Terms and Conditions. Amendment of Terms Luitpold Pharmaceuticals may amend these Terms and Conditions at any time. Your continued use of this Web site is conditioned on the Terms and Conditions stated at the time of your use. You should visit this page prior to using this Web site to determine the current Terms and Conditions to which you are bound. Content Disclaimer The information on this Web site applies only to the products discussed herein as approved in the United States of America.

The information provided on this Web site is not intended to substitute for the advice of a physician or other health care provider. You should not use the information provided on this Web site to diagnose or treat any medical condition or to make any other decision. Read and follow all instructions provided with products or as directed by your health care provider.

The information found on this Web site is up-to-date only through its date of last revision, and may become out of date over time. Luitpold Pharmaceuticals accepts no liability for the accuracy or completeness or use of, nor any liability to update, the information provided on this Web site.
Limitation of Warranties The information provided on this Web site is provided "AS IS" WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR NONINFRINGEMENT, to the extent allowed by applicable law. Use Restriction Luitpold Pharmaceuticals gives you permission to electronically copy and print in hard copy portions of the Web site for your personal, noncommercial use only. However, Luitpold Pharmaceuticals retains the copyright on all text, content, and graphics found on this Web site. This means that any other use, including, but not limited to, modification, distribution, or republication without Luitpold Pharmaceuticals' prior written permission is strictly prohibited. Nothing herein shall be considered to confer or grant any license or right under any copyright of Luitpold Pharmaceuticals, Inc. Corporate Identification and Trademarks The marks on the Web site are trademarks of Luitpold Pharmaceuticals, Inc., except for INJECTAFER®, VENOFER® and DEXFERRUM®, which are registered trademarks of VIFOR (International) Inc., St. Gallen, Switzerland, used with permission under license ("the Licensed Marks"). You may not use, copy, reproduce, republish, upload, post, transmit, distribute, or modify these marks in any way without Luitpold Pharmaceuticals' prior written permission. The use of Luitpold Pharmaceuticals' trademarks, including the Licensed Marks, on any other Web site is prohibited. Links Luitpold Pharmaceuticals prohibits the use of Luitpold Pharmaceuticals' trademarks, including the Licensed Marks, as a "link" on or to any other Web site unless Luitpold Pharmaceuticals has approved the link in advance. Nonconfidentiality Any information supplied by a visitor to this Web site shall be deemed as nonconfidential. Luitpold Pharmaceuticals shall have no obligation of any kind with respect to such information and shall be free to reproduce, use, disclose, and distribute the information to others without limitation. Luitpold Pharmaceuticals shall be free to use any ideas, concepts, know-how or techniques contained in such information for any purpose whatsoever including, but not limited to, developing, manufacturing, and marketing products incorporating such information.





Adequan® i.m. INDICATIONS For the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses. IMPORTANT SAFETY INFORMATION Studies have not been conducted to establish safety in breeding horses. WARNING: Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children. CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Adequan® I.A. INDICATIONS For the intra-articular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal joint in horses. IMPORTANT SAFETY INFORMATION Inflammatory joint reactions and septic arthritis have been reported following administration of Adequan® I.A. Joint sepsis, a rare but potentially life threatening complication, can occur after intra-articular injection. Use only in the carpal joint of horses. WARNING: Do not use in horses intended for human consumption. Keep this and all medications out of the reach of children. CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
BetaVet® INDICATIONS BetaVet® is indicated for the control of pain and inflammation associated with osteoarthritis in horses. IMPORTANT SAFETY INFORMATION For Intra-articular (I.A.) use in Horses. CONTRAINDICATIONS: BetaVet® is contraindicated in horses with hypersensitivity to betamethasone. Intra-articular injection of corticosteroids for local effect is contraindicated in the presence of septic arthritis. WARNINGS: Do not use in horses intended for human consumption. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Additionally, corticosteroids administered to dogs, rabbits and rodents during pregnancy have resulted in cleft palate in offspring and in other congenital anomalies including deformed forelegs, phocomelia and anasarca. Therefore, before use of corticosteroids in pregnant animals, the possible benefits to the pregnant animal should be weighed against potential hazards to its developing embryo or fetus. Human Warnings: Not for use in humans. For use in animals only. Keep this and all medications out of the reach of children. Consult a physician in the case of accidental human exposure. PRECAUTIONS: Corticosteroids, including BetaVet®, administered intra-articularly are systemically absorbed. Do not use in horses with acute infections. Acute moderate to severe exacerbation of pain, further loss of joint motion, fever, or malaise within several days following intra-articular injection may indicate a septic process. Because of the anti-inflammatory action of corticosteroids, signs of infection in the treated joint may be masked. Due to the potential for exacerbation of clinical signs of laminitis, glucocorticoids should be used with caution in horses with a history of laminitis, or horses otherwise at a higher risk for laminitis. Use with caution in horses with chronic nephritis, equine pituitary pars intermedia dysfunction (PPID), and congestive heart failure. Concurrent use of other anti-inflammatory drugs, such as NSAIDs or other corticosteroids, should be approached with caution. Due to the potential for systemic exposure, concomitant use of NSAIDs and corticosteroids may increase the risk of gastrointestinal, renal, and other toxicity. Consider appropriate wash out times prior to administering additional NSAIDs or corticosteroids. ADVERSE REACTIONS: Adverse reactions reported during a field study of 239 horses of various breeds which had been administered either BetaVet® (n=119) or a saline control (n=120) at five percent (5%) and above were: acute joint effusion and/or local injection site swelling (within 2 days of injection), 15% BetaVet® and 13% saline control; increased lameness (within the first 5 days), 6.7% BetaVet® and 8.3% saline control; loose stool, 5.9% BetaVet® and 8.3% saline control; increased heat in joint, 2.5% BetaVet® and 5% saline control; and depression, 5.9% BetaVet® and 1.6% saline control. DOSAGE AND ADMINISTRATION: Shake well immediately before use. Use immediately after opening, then discard any remaining contents. Use immediately after opening, then discard any remaining contents. RX ONLY


Online ordering system for veterinarians Purchase Adequan® and BetaVet® Online Now! Or Call Customer Service Today!
(800) 458-0163
Online ordering system for veterinarians Purchase Adequan® and BetaVet® Online Now!

Or Call Customer Service Today! (800) 458-0163


Copyright © 2016 Luitpold Pharmaceuticals, Inc. All rights reserved.
Adequan®, BetaVet® and the Horse Head design are registered trademarks of Luitpold Pharmaceuticals, Inc.
©Luitpold Animal Health, division of Luitpold Pharmaceuticals, Inc. 2016. Luitpold Animal Health website, PP-AA-US-0007 10/2016